Nintedanib
Nintedanib
Nintedanib (pronounced nin-ted-a-nib) is a medication used in the treatment of idiopathic pulmonary fibrosis and some types of cancer. It is a small molecule that inhibits multiple receptor tyrosine kinases.
Etymology
The name "Nintedanib" is derived from the chemical name of the drug, which is Nintedanib ethanesulfonate. The prefix "Nin-" is derived from the chemical structure of the drug, which contains a nintedanib moiety. The "-danib" suffix is common in drugs that inhibit tyrosine kinases.
Usage
Nintedanib is used in the treatment of idiopathic pulmonary fibrosis (IPF), a condition that causes progressive scarring of the lungs. It is also used in the treatment of some types of cancer, including non-small cell lung cancer and colorectal cancer.
Mechanism of Action
Nintedanib works by inhibiting multiple receptor tyrosine kinases, which are enzymes that play a key role in cell growth and proliferation. By inhibiting these enzymes, Nintedanib can slow the growth of cancer cells and reduce the progression of fibrosis in the lungs.
Related Terms
- Tyrosine kinase inhibitor
- Idiopathic pulmonary fibrosis
- Non-small cell lung cancer
- Colorectal cancer
See Also
- List of tyrosine kinase inhibitors
- List of medications used in oncology
- List of medications used in pulmonology
External links
- Medical encyclopedia article on Nintedanib
- Wikipedia's article - Nintedanib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski